Enhanced Recovery After Surgery: A Review.
Olle Ljungqvist, Michael Scott, Kenneth C Fearon
https://pubmed.ncbi.nlm.nih.gov/28097305/Actively Recruiting
Led by University of Arizona · Updated on 2026-07-23
150
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating the outcomes of patients undergoing outpatient colorectal surgery to determine if same-day colectomy is a safe and viable option for certain individuals requiring colon and rectal surgery. This prospective cohort study focuses on patients aged 18 to 70 undergoing specific types of robotic-assisted colectomy procedures at a single institution. The study aims to assess hospital readmission rates within 30 days post-procedure as the primary outcome. Participants will receive extensive education before surgery, including instructions on medication management, bowel preparation, and antibiotics. Caregivers are also included in this education. After surgery, patients receive a custom discharge instruction sheet and follow-up support via phone or virtual visits on postoperative days 1 and 3. An in-person clinic visit occurs between days 5 and 7. Medical records are monitored for six months to track emergency visits, readmissions, and various postoperative complications. Throughout the study, researchers will assess several outcomes such as surgical site infections, bleeding requiring transfusions, anastomotic leaks, postoperative ileus, reoperations, and mortality within 30 days after surgery. Monitoring includes tracking acute kidney injury, respiratory support needs, and reinterventions. Participants are expected to have access to communication devices and a caregiver at home. This involvement helps ensure safety and gather comprehensive data on recovery and complications.
CONDITIONS
Same-Day Colectomy: is it Safe for Patients?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Arizona
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Same-Day Discharge Protocol (Trial) | Inpatient Hospital Recovery (Current Practice) |
|---|---|---|
| What it is | A structured perioperative protocol allowing selected adults having minimally invasive colectomy to be discharged on the same day as surgery. The protocol includes extensive patient and caregiver education, standardized perioperative management, custom discharge instructions, early post-discharge contact, and close follow-up. | Hospital-based recovery following minimally invasive colectomy, typically with a 1-4 day inpatient stay as part of an enhanced recovery after surgery (ERAS) program. Patients receive structured perioperative care, in-hospital monitoring, and discharge when key recovery milestones are met. |
| Role in trial | This is the investigational pathway being formally evaluated in the trial for safety and feasibility in a defined high-selection colorectal surgery population. | Represents the current clinical benchmark for postoperative care and outcomes in similar patients treated outside a same-day-discharge protocol. |
| Primary use | To test whether same-day discharge with enhanced perioperative education and follow-up can be applied safely to carefully selected patients after robotic-assisted colectomy. | To provide continuous hospital monitoring and supportive care following colorectal surgery, optimizing recovery and reducing complications per established ERAS protocols. |
| How it is given or performed | Eligible patients receive detailed preoperative and perioperative education, undergo minimally invasive (robotic-assisted) colectomy, and—if stable—are discharged home the same day. Structured virtual or phone follow-ups occur on postoperative days 1 and 3, plus an in-clinic visit by day 5-7. A caregiver at home and access to phone or computer are required. | Patients are admitted to hospital after minimally invasive colectomy and monitored through recovery. Standard milestones for discharge include pain control, return of bowel function, and mobility. Most are discharged between 1 and 4 days post-surgery, with in-person follow-up scheduled after discharge. |
| Evidence status | Safety and feasibility data for same-day discharge are emerging from small pilot studies and prospective cohorts, but outcomes such as readmission and complication rates require broader validation in diverse populations. | Substantial evidence from large studies and ERAS implementation trials supports inpatient recovery as safe and effective, with low complication and readmission rates in appropriately selected patients. |
| Important limitations | The same-day discharge protocol is only suitable for carefully screened, highly selected patients, and requires reliable caregiving at home and telecommunication availability. Results may not generalize to older, higher-risk, or socially unsupported patients; long-term safety and broader implementation remain under study. | In-hospital recovery increases resource use and patient exposure to hospital-related risks. While effective for most, even ERAS protocols may not prevent all postoperative complications, and hospital stays still pose a risk of hospital-acquired conditions. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 7 days post-surgery
Participants undergo same-day robotic-assisted colectomy followed by discharge with detailed education and caregiver support. Follow-up includes phone or virtual visits on postoperative days 1 and 3 and an in-person clinic visit between days 5 and 7.
Phone or virtual visits on days 1 and 3; 1 clinic visit between days 5 and 7
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Olle Ljungqvist, Michael Scott, Kenneth C Fearon
https://pubmed.ncbi.nlm.nih.gov/28097305/Stephen Campbell, Alessandro Fichera, Scott Thomas...
https://pubmed.ncbi.nlm.nih.gov/34970026/Benoit Gignoux, Marilyn Gosgnach, Thomas Lanz...
https://pubmed.ncbi.nlm.nih.gov/29727328/B Gignoux, A Pasquer, A Vulliez...
https://pubmed.ncbi.nlm.nih.gov/25661787/Timothy E Miller, Julie K Thacker, William D White...
https://pubmed.ncbi.nlm.nih.gov/24781574/S Bourgouin, T Monchal, G Schlienger...
https://pubmed.ncbi.nlm.nih.gov/33349570/Christina M Papageorge, Qianqian Zhao, Eugene F Foley...
https://pubmed.ncbi.nlm.nih.gov/27451872/Lawrence Lee, Jules Eustache, Marie Tran-McCaslin...
https://pubmed.ncbi.nlm.nih.gov/35419638/Karleigh R Curfman, Ashwini S Poola, Gabrielle E Blair...
https://pubmed.ncbi.nlm.nih.gov/35570059/Adam Studniarek, Daniel J Borsuk, Kunal Kochar...
https://pubmed.ncbi.nlm.nih.gov/33094353/University of Arizona
Lead Sponsor